Showing posts with label oligodendrocytes. Show all posts
Showing posts with label oligodendrocytes. Show all posts

Friday, 15 December 2023

Ultrastructural Pathology of Oligodendrocytes and Myelinated Fibers in Prefrontal white Matter in Schizophrenia | Chapter 12 | Advanced Concepts in Medicine and Medical Research Vol. 7

 In this place chapter, we proposed to perform a subjective and morphometric study of the ultrastructure of oligodendrocytes in BA 10 white matter (WM) in emotional disorder and in normal controls and to present ultrastructural alterations of myelinated  fibers previously discovered in BA 10 WM in schizophrenia distinguished to normal controls.Power microscopy and morphometry were used in the study. The size, capacity density (Vv), and number (N) of oligodendrocyte organelles were calculated in 21 patients accompanying schizophrenia and 20 normal controls. The dossier were examined utilizing the Kolmogorov–Smirnov test for normality. Pearson equivalence analysis was used to expect probable friendships between the limits measured and age, review after death interval, neuroleptic treatment, and affliction duration.In emotional disorder, we detected oligodendrocyte increase, vacuolation, a lack of ribosomes and mitochondria, and an accumulation of lipofuscin granules when distinguished to controls. Morphometry revealed a solid decrease in Vv and N of mitochondria and an increase in Vv and N of lipofuscin granules and vacuoles in schizophrenia oligodendrocytes distinguished to controls. Abnormalities of myelinated fibers in WM in emotional disorder compared to normal controls contained altered oligodendrocyte/axon interplay and myelin/axon integrity, axonal disintegration and degeneration of myelin sheaths and myelinated fibers.Alterations of oligodendrocytes and myelinated fibers in emotional disorder provide evidence for the upset of their energy, lipid and protein absorption in prefrontal WM. Abnormalities in oligodendrocytes and myelinated fibers power disturb axonal integrity and circuits and contribute to the pathophysiology of emotional disorder.

Author(s) Details:

Uranova N. A.,
Laboratory of Clinical Neuropathology, Mental Health Research Center, Moscow, Russia.

Please see the link here: https://stm.bookpi.org/ACMMR-V7/article/view/12767

Wednesday, 6 September 2023

Glial Cell-Targeted Treatments for Bipolar Disorder: A Systematic Review of Available Data and Clinical Perspectives | Chapter 6 | Novel Research Aspects in Medicine and Medical Science Vol. 2

 Bipolar disorder poses meaningful challenges to the mental health society, and effective situation strategies are crucial in directing this complex condition. This paper presents a comprehensive orderly review of treatment approaches for bipolar disorder, accompanying a specific devote effort to something synthesizing evidence from treatment directions and clinical trials. A orderly search was conducted utilizing Google Scholar, yielding 375 relevant documents, during the ending from June 1, 2022, to August 30, 2022.The primary objective of this study search out provide an revised and rigorous evaluation of the existent treatment guidelines and dispassionate trial evidence for bipolar disorder. By checking a wide range of interventions, this review aims to offer clinicians and investigators valuable insights into evidence-located practices for the management of this disorder.The verdicts of this review reveal essential situation modalities for manic-depressive illness. Lithium emerges as a critical pharmacological mediation for controlling and lessening severe mood adventures. Additionally, olanzapine demonstrates productiveness in managing acute crazy or mixed episodes of manic-depressive illness. Moreover, Cariprazine shows promise in achieving better influence or remission outcomes.  Lurasidone is emphasize for its potential in reconstructing cognitive performance between individuals accompanying bipolar disorder.Furthermore, this study underscores the significance of addressing co-morbid environments in bipolar disorder administration. For instance, quetiapine is identified as an effective situation for improving sleep condition and co-morbid anxiety. The consolidation of carbamazepine and lithium emerges as a favored approach in managing psychotic madness with co-morbidity. Adjunctive olanzapine or lamotrigine is urged for treating co-nasty anxiety, while mood stabilizers confirm beneficial in calling co-morbid bulimia. Moreover, fatigue situation considerations suggest the exercise of a dawn simulator.In agreements of dietary recommendations, the review stresses the significance of adopting a healthful diet. Probiotics intake and attention to the balance of oily acids are suggested to support overall prosperity in patients with manic-depressive illness.In conclusion, this systematic review provides inclusive insights into evidence-located treatment options for manic-depressive illness. By evaluating the influence of various interventions, it offers clinicians and scientists valuable guidelines to improve the management of bipolar disorder efficiently. The findings of this study focal point the critical function of treatment guidelines and dispassionate trials in numbering the knowledge base and improving effects for individuals endure bipolar disorder.

Author(s) Details:

Julia Wang,
Lumiere Academy, Shanghai, China.

Please see the link here: https://stm.bookpi.org/NRAMMS-V2/article/view/11802